# HIV Persistence and Viral Reservoirs

> **NCT01025427** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 16 (actual)

## Conditions studied

- HIV
- HIV Infections

## Interventions

- **DRUG:** Raltegravir, tenofovir/emtricitabine

## Key facts

- **NCT ID:** NCT01025427
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-11
- **Final completion:** 2013-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025427, "HIV Persistence and Viral Reservoirs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01025427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*